Historical review from 2026-09-15. Current price and availability are unconfirmed; check the original marketplace.
Nuria shows exceptional unit economics—95% profit margin and a 2.2x annual profit multiple are outstanding—but the $397/mo revenue is far below the threshold for a viable acquisition target. At this scale, the business generates only $4,527 annual profit, which does not support meaningful leverage or downside protection. The 11-month operating history and mobile-app category add execution risk. A buyer should establish whether this represents genuine product-market fit with growth trajectory, or early-stage traction that requires substantial capital and operational scaling before generating acquisition-grade returns.
The core software—a calorie tracker with habit-building tools—is fully reproducible using AI-assisted development with modern frameworks (React Native or Flutter), third-party nutrition APIs (USDA FoodData Central, Nutritionix), and managed databases. Build cost is $3.5K–$8K; timeline 6 weeks at solo-founder pace with AI tooling. The decisive factor is that Nuria has not yet established durable, repeatable customer acquisition or meaningful unit retention. You would be purchasing only $397/mo revenue and an 11-month-old codebase, not a proven go-to-market engine or customer moat. Building a similar app and investing the acquisition price into marketing would offer better expected return and lower risk of acquiring an early-stage product dependent on founder execution.
Cash estimate includes the AI tools, APIs and infrastructure needed for a solo founder to recreate the software. Build time is informational and lightly weighted. The verdict is driven mainly by customers, users, verified earnings, retention, distribution, brand, data and operating history.
More than a calorie tracker. Nuria helps users build healthier eating habits with its own set of habit-building tools and nutrition-focused features.
Opens the original listing on TrustMRR
Get new listings with asking prices, monthly profit, deal scores, and key risks.
The best reviewed deals, concise and evidence-first. Unsubscribe anytime.
Preliminary screening based on marketplace and public data. Verify all financial, legal, technical, customer, and operational claims independently before making an acquisition decision. This is not financial or legal advice.